French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of 8 medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS).
Three decisions were released for coronary stents:
- ULTIMASTER, drug-eluting coronary stent (request for amendment, approved)
- RESOLUTE ONYX, drug-eluting coronary stent (request for amendment, approved)
- BIOSS LIM C, drug-eluting bifurcation coronary stent (application for registration, approved)
Two decisions were published for portable oxygen concentrators:
- ZEN-O RS-00500, portable oxygen concentrator (application for registration, approved)
- XPO2, portable oxygen concentrator (application for renewal of registration, approved)
Three other decisions:
- UROLIFT, intra-prostatic implant (application for registration, approved)
- AXIUM, non-rechargeable implantable system for spinal ganglion stimulation (application for registration, approved)
- Insulin pumps (request for amendment of technical specifications, approved)
See list of decisions in French here.
Subscribe to our newsletter delivered every second week not to miss important reimbursement information.